Rhythm Pharmaceuticals (FRA:1RV) Total Debt per Share : €0.06 (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Rhythm Pharmaceuticals Total Debt per Share?

€0.06 (As of Mar. 2025)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Rhythm Pharmaceuticals's Total Debt Per Share for the quarter that ended in Mar. 2025 was €0.06.

Rhythm Pharmaceuticals Total Debt per Share Historical Data

The historical data trend for Rhythm Pharmaceuticals's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Total Debt per Share Chart

Rhythm Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Debt per Share

Get a 7-Day Free Trial

0.06

0.05

0.03

0.02

0.06

Rhythm Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Debt per Share	Get a 7-Day Free Trial															0.02	0.06	0.06	0.06	0.06

Rhythm Pharmaceuticals Total Debt per Share Calculation

Rhythm Pharmaceuticals's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(3.8	+	0.0)	/	62.4
	=	0.06

Rhythm Pharmaceuticals's Total Debt Per Share for the quarter that ended in Mar. 2025 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(3.6	+	0.2)	/	63.1
	=	0.06

Rhythm Pharmaceuticals Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhythm Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (FRA:1RV) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

RYTM:USA

Address

222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116

Website

https://www.rhythmtx.com

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

Rhythm Pharmaceuticals Headlines

No Headlines